Sort
51,570 grants matching “autoimmune disease”
Role of TL1A in Severity of Crohn's Disease Inflammation
$421,468Stephan R. Targan · Cedars-Sinai Medical Center · R01 · FY2010 · DK
Combining AD epitope vaccine with innate immunity
$421,437David Hastings Cribbs · University Of California-Irvine · R01 · FY2008 · NS
Combining AD epitope vaccine with innate immunity
$421,423David Hastings Cribbs · University Of California-Irvine · R01 · FY2007 · NS
Characterization of SLE-Susceptability Loci on Mouse Chromosome 1
$421,409Laurence Morel · University Of Florida · R01 · FY2009 · AI
Deregulation of Cellular IkB Kinases by HTLV1 Tax
$421,337Vanderbilt University · R01 · FY2005 · CA
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation
$421,296Stephen D Miller · Northwestern University At Chicago · R01 · FY2019 · NS
Shared Resource: Therapeutic Manufacturing
$421,294Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2016 · CA
Macrocyclic Peptidyl Inhibitors of NEMO-IKK Interaction
$421,290Dehua Pei · Ohio State University · R01 · FY2019 · CA
Macrocyclic Peptidyl Inhibitors of NEMO-IKK Interaction
$421,290Dehua Pei · Ohio State University · R01 · FY2021 · CA
Macrocyclic Peptidyl Inhibitors of NEMO-IKK Interaction
$421,290Dehua Pei · Ohio State University · R01 · FY2020 · CA
Aberrant Signaling in B1 Cells
$421,250Thomas L Rothstein · Feinstein Institute For Medical Research · R01 · FY2015 · AI
Technologies for Directed Evolution of Glycoaptamers
$421,249Isaac Jonathan Krauss · Brandeis University · R01 · FY2023 · GM
Pseudophosphatase MK-STYX: A Signaling Molecule for Differentiation
$421,220Shanta' D Hinton · College Of William And Mary · R15 · FY2020 · NS
Complement-mediated injury of the kidney: New mechanisms and novel therapies
$421,214Joshua M Thurman · University Of Colorado Denver · R01 · FY2025 · DK
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2022 · AG
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2021 · AG
Development of a Clinical Screening Platform for Type 1 Diabetes
$421,182David H Wagner · Op-T-Mune, Inc. · R42 · FY2017 · DK
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
$421,107Jamie Berta Spangler · Johns Hopkins University · R01 · FY2021 · EB
Mechanism of Triclosan Disruption of Mast Cell Function
$421,068Julie Ann Gosse · University Of Maine Orono · R15 · FY2014 · ES
Deregulation of Cellular IkB Kinases by HTLV1 Tax
$421,051Dean Ballard · Vanderbilt University · R01 · FY2008 · CA
Signaling functions of Peli family of E3 ubiquitin ligases
$421,034Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
$421,004Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AI
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
$421,004Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AI
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
$421,004Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AI
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
$421,004Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AI